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Chronic obstructive pulmonary disease (COPD) is a 
common, preventable but incurable condition currently 
ranked third in global mortality estimates.[1] Worldwide, 
65 million people are estimated to have moderate to severe 
COPD, and the disease accounts for 3 million deaths 
annually, of which 90% are said to occur in low- and middle-income 
countries. Yet, despite these staggering numbers, COPD remains both 
under-recognised and undertreated in most populations, also in South 
Africa (SA).[2] There are many reasons for this, not least of which is 
the attitude of clinicians, which can often be fatalistic with regard to 
COPD. This edition of CME highlights key aspects of the diagnosis[3] 
and treatment – pharmacological[4] and non-pharmacological[5] – 
and new developments in the management of severe disease.[6] 
Furthermore, we have included articles focusing on non-smoking-
related COPD[7] and tips for good spirometry.[8] 
COPD is often a challenging disease for the patient and the doctor. 
Even the name causes much head-scratching for many sufferers. 
‘Asthma I know’, and ‘emphysema I have heard of ’, but COPD – a complex 
syndrome extending from chronic bronchitis to emphysema – is not well 
understood or easily explained. This is in part a problematic historical 
nomenclature issue, but as knowledge grows, there are increasing attempts 
to split COPD into more clinically relevant phenotypes. It is hoped that this 
will allow for a clearer understanding and better treatment choices. 
Tobacco smoking is still the predominant cause of COPD 
worldwide, but there is a growing understanding of the importance 
of non-tobacco causes. SA is unique in many ways, having significant 
contributions from tuberculosis, HIV and biomass as well as mining 
exposure, creating ‘colliding epidemics’, with resultant chronic lung 
disease.[9] Unfortunately, very little is known about the natural history 
or the response to therapy of these non-smoking forms of COPD, 
which are currently receiving due attention. For smoking-related 
COPD, it is critical that smokers cease smoking; the South African 
Clinical Practice Guideline is available to assist clinicians in helping 
their patients quit.[10] 
So why bother making a diagnosis of COPD and distinguishing it 
from asthma? This is a critical question, especially in resource-limited 
settings with limited access to spirometry and few treatment options. 
The first good reason we would propose is ‘managing expectations’ 
for both the physician and patient. Many patients are resigned to 
their chronic symptoms; however, if truly asthmatic, neither party 
should accept this lightly. In most asthma patients complete control 
of symptoms is possible with good therapy.[11] In COPD, by contrast, 
complete symptom resolution is not necessarily realistic. However, 
with the arrival of new long-acting muscarinic antagonists and ultra-
long-acting β2-agonists, improvement in symptom control may be 
dramatic. Secondly, the long-term prognosis is significantly worse in 
COPD compared with asthma and patients need to be appropriately 
counselled regarding their expected disease progression. The final 
reason is the choice of drugs to manage the disease. Inhaled 
corticosteroids are undoubtedly the mainstay of asthma therapy[12] 
compared with COPD, where bronchodilators are the anchor and 
inhaled corticosteroids are reserved for a select group.[2]
Hope is not lost with COPD. Despite it being incurable, with 
irreversible lung function impairment, much can still be done. Early 
detection and smoking cessation will slow the disease progression. 
Appropriate and adequate therapy to improve symptoms and prevent 
the ominous progression of acute exacerbations, in addition to 
vaccination, pulmonary rehabilitation and good nutrition, will ensure 
that COPD patients continue to live active lives. Novel therapies 
are being developed and evaluated in 
SA, which could potentially improve 
symptoms of patients with the most 
severe disease. Consider the diagnosis 
early, confirm it with spirometry 
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